TransMedics Wraps Up $35.4M

Xconomy Boston — 

TransMedics, an Andover, MA, developer of systems for transporting organs for transplant, has pulled in $35.4 million in an equity offering that includes about $9 million from convertible debt, according to an SEC filing. Partners of Flagship Ventures, Foundation Capital, and Kleiner Perkins Caufield & Byers are listed as directors on the filing, which the company declined to comment on further at this time. In 2008, TransMedics withdrew its plans for an initial public offering worth up to $86 million, due to unfavorable market conditions.

By posting a comment, you agree to our terms and conditions.

Comments are closed.